---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295131985.md"
description: "Protagonist Therapeutics shares are trading higher after Barclays raised its price target on the stock from $151 to $153."
datetime: "2026-08-06T17:41:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295131985.md)
  - [en](https://longbridge.com/en/news/295131985.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295131985.md)
---

# 

Protagonist Therapeutics shares are trading higher after Barclays raised its price target on the stock from $151 to $153.

### Related Stocks

- [PTGX.US](https://longbridge.com/en/quote/PTGX.US.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)

## Related News & Research

- [Protagonist Therapeutics grants inducement equity awards for 7,175 shares to new hires at USD 155.1 strike price](https://longbridge.com/en/news/296264888.md)
- [Protagonist Therapeutics (NASDAQ:PTGX) CEO Sells 65,761 Shares of Stock](https://longbridge.com/en/news/295781258.md)
- [Protagonist Therapeutics CEO Dinesh V. Patel disposes of USD 14.89 million in common shares](https://longbridge.com/en/news/295717591.md)
- [Sugar Prices Rally as India Cuts Sugar Import Duties](https://longbridge.com/en/news/296518344.md)
- [Protagonist Therapeutics (PTGX) Swings To Net Income, Is The Valuation Too Expensive?](https://longbridge.com/en/news/295354544.md)